As of 2025-11-13, the Intrinsic Value of Geneuro SA (GNRO.PA) is -2.48 EUR. This GNRO.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.04 EUR, the upside of Geneuro SA is -6,489.12%.
Based on its market price of 0.04 EUR and our intrinsic valuation, Geneuro SA (GNRO.PA) is overvalued by 6,489.12%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.48 - -2.48 | -2.48 | -6,489.12% |
| P/E | (3.45) - (3.45) | (3.09) | -8054.5% |
| DDM - Stable | (1.06) - (3.40) | (2.23) | -5846.3% |
| DDM - Multi | (0.20) - (0.62) | (0.32) | -913.2% |
| Market Cap (mil) | 1.15 |
| Beta | 1.29 |
| Outstanding shares (mil) | 29.76 |
| Enterprise Value (mil) | 6.26 |
| Market risk premium | 5.82% |
| Cost of Equity | 26.99% |
| Cost of Debt | 5.00% |
| WACC | 6.79% |